356 results on '"Rupenthal, Ilva D."'
Search Results
2. Contributors
3. Tissue-based models for ocular permeability studies
4. Mechanism of Ocular Penetration of Lipophilic Drugs from Lipophilic Vehicles
5. Preclinical characterization of water-free cyclosporine eye drops – Factors impacting ocular penetration ex vivo and in vivo
6. Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
7. Blocking the inflammasome: A novel approach to treat uveitis
8. Systemic Inflammasome Biomarkers as Predictors of Diabetic Retinopathy Progression: Evidence from a Pilot Study
9. Xentry-Gap19 inhibits Connexin43 hemichannel opening especially during hypoxic injury
10. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown
11. Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
12. Penetration Routes to Retina and Posterior Segment
13. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy
14. Depot formulations to sustain periocular drug delivery to the posterior eye segment
15. Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode.
16. Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
17. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease
18. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia
19. 3-Dimensionally ordered macroporous PEDOT ion-exchange resins prepared by vapor phase polymerization for triggered drug delivery: Fabrication and characterization
20. Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease
21. Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids
22. Drug-device combination approaches for delivery to the eye
23. Chapter 4.6 - Tissue-based models for ocular permeability studies
24. Non-aqueous formulations in topical ocular drug delivery – a paradigm shift?
25. Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery
26. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye
27. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
28. A mutually decoupled coil system to improve sensitivity of inductively coupled communication.
29. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy
30. Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels
31. Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
32. Modern approaches to the ocular delivery of cyclosporine A
33. Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
34. Connexin43 in retinal injury and disease
35. Neuroprotection in the treatment of glaucoma – A focus on connexin43 gap junction channel blockers
36. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles – Closing the gap in retinal ischaemia
37. Nanotechnology for ocular drug delivery
38. List of Contributors
39. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
40. Extracellular Vesicles as Biomarkers and Therapeutics for Inflammatory Eye Diseases
41. In vitro and ex vivo corneal penetration and absorption models
42. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS
43. Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems
44. Preparation and Characterisation of a Cyclodextrin-Complexed Mānuka Honey Microemulsion for Eyelid Application
45. Preclinical confirmation of UVC efficacy in treating infectious keratitis
46. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs
47. Erratum to “Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection” [Eur. J. Pharm. Biopharm. 119 (2017) 125–136]
48. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection
49. Intracellular oligonucleotide delivery using the cell penetrating peptide Xentry
50. Ocular drug delivery—eye on innovation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.